Keywords: almirall, licenses, triptan, ortho-mcneil, spanish, multinational, drugmaker
Almirall licenses triptan to Ortho-McNeil
Article | 28 April 2003
Spanish multinational drugmaker Almirall has granted a license toJohnson & Johnson's Ortho-McNeil Pharmaceutical subsidiary for Axert (almotriptan malate) in the USA. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
